Wlazłowski M, Celińska W, Maciejka-Kapuścińska L, Płoszyńska A, Idczak E
I Kliniki Chorób Dzieci w Gdańsku.
Pol Tyg Lek. 1994;49(12-13):296-7.
The treatment of the acute lymphoblastic leukemia in childhood includes frequent administration of L-asparaginase by intravenous route. L-asparaginase is an enzyme produced by E. coli and Erwinia chrysanthemi strains. Adverse reactions produced by L-asparaginase are numerous, and pancreatitis is being the most severe. Children with the acute lymphoblastic leukemia were followed up for 2 years. Hyperglycaemia and glycosuria were noted in 10% of them resulting in L-asparaginase cessation or replacement by less toxic agents. The acute pancreatitis was produced in 8% of the patients, and was treated typically.
儿童急性淋巴细胞白血病的治疗包括通过静脉途径频繁给予L-天冬酰胺酶。L-天冬酰胺酶是由大肠杆菌和菊欧文氏菌菌株产生的一种酶。L-天冬酰胺酶产生的不良反应众多,其中胰腺炎最为严重。对患有急性淋巴细胞白血病的儿童进行了2年的随访。其中10%的儿童出现高血糖和糖尿,导致停用L-天冬酰胺酶或用毒性较小的药物替代。8%的患者发生了急性胰腺炎,并进行了常规治疗。